Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria.
Nicolò CapsoniPietro BelloneStefano AlibertiGiovanni SotgiuDonatella PavanelloBenedetto VisintinElena CallistoLaura SaderiDavide SoldiniLuca LarderaValter MonzaniAnna Maria BrambillaPublished in: Multidisciplinary respiratory medicine (2019)
In light of the prevalence and impact of MDR bacteria causing sepsis in patients coming from the community, physicians should consider ESBL coverage when starting an empiric antibiotic therapy in patients with specific risk factors, especially in the presence of septic shock.
Keyphrases
- risk factors
- septic shock
- end stage renal disease
- multidrug resistant
- healthcare
- ejection fraction
- chronic kidney disease
- intensive care unit
- escherichia coli
- primary care
- prognostic factors
- acute kidney injury
- stem cells
- peritoneal dialysis
- type diabetes
- mesenchymal stem cells
- cystic fibrosis
- pseudomonas aeruginosa
- klebsiella pneumoniae
- smoking cessation
- cell therapy
- chemotherapy induced
- affordable care act